Recent research conducted by the Wender Group, consisting of 19 chemists as well as Stanford professor Paul Wender, could point to the existence of potential… Continue Reading »
Jade balloons tied to bikes all over campus Monday morning were the first of many indicators of Hepatitis B Awareness Week. Featuring speakers and events all over campus, the awareness week was organized by Team HBV, an outreach arm of the Jade Ribbon Campaign led by the Asian Liver Center at the Stanford School of Medicine.
The Bridge Center for Peer Counseling has experienced a spike in calls this quarter, possibly in relation to two recent student deaths, according to Bridge counselor Akshay Gopalan ‘12 who spoke to The Daily in advance of a discussion about dealing with grief and suicide on campus.
Due to health and transparency concerns, some Stanford students and faculty have expressed support for a proposed ballot initiative that would require the labeling of genetically modified food on retail grocery products in California. The California Right to Know Genetically Engineered Food Act of 2012 requires 504,760 signatures to appear on the Nov. 2012 ballot in California.
This summer, the Stanford University School of Medicine will welcome Robert Harrington, M.D., as its new chair. Harrington currently heads the Duke Clinical Research Institute in North Carolina, the largest clinical trial research organization in the world. The Daily spoke with him about his goals for this new position, his upcoming transition across the country and current room for progress at the School of Medicine.
No Stanford-bound medicine was included in the about 1 million packs of birth control pills voluntarily recalled by drug manufacturer Pfizer on Jan. 31 due to incorrect packaging, said a Stanford health administrator. While Vaden Health Center at Stanford does not carry any of the affected medication, campus Peer Health Educators (PHE) have been briefed on how to handle the recall, wrote Robyn Tepper, director of medical services at Vaden, in an email to The Daily.
The Stanford Cancer Institute opened a new clinic this week with the intention of providing better care for patients after cancer treatment. The clinic, which will initially to be open only to gynecologic cancer survivors, will focus on assisting patients through issues such as fatigue, anxiety, body image, sexual function and relationships, according to a press release from the Stanford School of Medicine.
On Jan. 12, the Stanford biodesign program and the Stanford School of Medicine signed a memorandum of understanding (MOU) with the Food and Drug Administration (FDA). This memorandum gives both organizations a foundation that allows future collaboration on projects, such as working to improve the regulatory process for innovations in medical technology.